LLY vs SCNX · P/E 39, rev $22.97B vs rev $400.0K
Eli Lilly and Company (LLY) versus Scienture Holdings, Inc. (SCNX) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
Scienture Holdings, Inc. (SCNX) is a pharmaceutical retailers company listed on NASDAQ.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported SCNX revenue for 2026-06-30 was $400.0K. Net income was -$6.2M. SCNX currently screens at market cap $15.8M.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. SCNX currently screens at market cap $15.8M.
Not investment advice. Open the LLY and SCNX stock pages for the full models.
Not investment advice.